info/FAQ

Research articles

My Pages

Stat

Members: 3645
Articles: 2'506'133
Articles rated: 2609

27 April 2024

» search

Search for articles, messages and online reviews

Results 1 to 20 of 46 for query "A B Rickinson". (0.00 sec.)

[ 1 2 3 ] Next

HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells
A B Rickinson; L E Wallace; M A Epstein;
28 Feb 1980 / Nature, 283 (5750), 865-7

Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis
C D Gregory; C Dive; S Henderson; C A Smith; G T Williams; J Gordon; A B Rickinson;
14 Feb 1991 / Nature, 349 (6310), 612-4

Epstein-Barr virus infection and replication in a human epithelial cell system
Q X Li; L S Young; G Niedobitek; C W Dawson; M Birkenbach; F Wang; A B Rickinson;
26 Mar 1992 / Nature, 356 (6367), 347-50

HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population
P O de Campos-Lima; R Gavioli; Q J Zhang; L E Wallace; R Dolcetti; M Rowe; A B Rickinson; M G Masucci;
2 Apr 1993 / Science, 260 (5104), 98-100

Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.
Rowe, M; Peng-Pilon, M; Huen, D S; Hardy, R; Croom-Carter, D; Lundgren, E; Rickinson, A B;

Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance
C M Rooney; M Rowe; L E Wallace; A B Rickinson;
17 Oct 1985 / Nature, 317 (6038), 629-31

Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation
D J Moss; A B Rickinson; L E Wallace; M A Epstein;
25 Jun 1981 / Nature, 291 (5817), 664-6

Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation
C W Dawson; A B Rickinson; L S Young;
19 Apr 1990 / Nature, 344 (6268), 777-80

Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen
L E Wallace; A B Rickinson; M Rowe; M A Epstein;
3 Jun 1982 / Nature, 297 (5865), 413-5

10.

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
Rowe, M; Rowe, D T; Gregory, C D; Young, L S; Farrell, P J; Rupani, H; Rickinson, A B;
6 Jun 2005

11.

Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Wang, F; Gregory, C D; Rowe, M; Rickinson, A B; Wang, D; Birkenbach, M; Kikutani, H; Kishimoto, T; Kieff, E;

12.

Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.
Rickinson, A B; Young, L S; Rowe, M;

13.

Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.
Murray, R J; Young, L S; Calender, A; Gregory, C D; Rowe, M; Lenoir, G M; Rickinson, A B;

14.

Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
Rowe, M; Young, L S; Cadwallader, K; Petti, L; Kieff, E; Rickinson, A B;

15.

The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear, A L; Rowe, M; Kurilla, M G; Lee, S; Henderson, S; Kieff, E; Rickinson, A B;

16.

Methylation of Transcription Factor Binding Sites in the Epstein-Barr Virus Latent Cycle Promoter Wp Coincides with Promoter Down-Regulation during Virus-Induced B-Cell Transformation
Tierney, R. J.; Kirby, H. E.; Nagra, J. K.; Desmond, J.; Bell, A. I.; Rickinson, A. B.;

17.

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
Rowe, M; Lear, A L; Croom-Carter, D; Davies, A H; Rickinson, A B;

18.

Absence of infectious Epstein-Barr virus in blood in acute infectious mononucleosis
A B Rickinson; M A Epstein; D H Crawford;
20 Nov 1975 / Nature, 258 (5532), 236

19.

A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
Morgan, S M; Wilkinson, G W; Floettmann, E; Blake, N; Rickinson, A B;

20.

Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort
Yao, Q. Y.; Croom-Carter, D. S. G.; Tierney, R. J.; Habeshaw, G.; Wilde, J. T.; Hill, F. G. H.; Conlon, C.; Rickinson, A. B.;

[ 1 2 3 ] Next

ScienXe.org
» my Online CV
» Free

News, job offers and information for researchers and scientists:

home

contact

sitemap

Search for articles, messages and online reviews

Search in 2'506'133 articles.